REBYOTA for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study

Go Back to All Clinical Trials

REBYOTA for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
C.diff
Age: Between 18 Year(s) - 150 Year(s)
Gender: Male or Female

Other Inclusion Criteria:
1. Age ≥18 years
2. Diagnosis of rCDI as determined by the treating physician.
3. Completed antibiotic treatment for the presenting rCDI episode.
4. Prescription for REBYOTA to prevent rCDI according to the approved indication.

You may not be eligible for this study if the following are true:

1. Currently enrolled in an interventional clinical trial.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies